Medtech Monthly, Ep. 2: Where Does Diabetes Tech Stand In 2022?
Executive Summary
In this edition of Medtech Monthly, Robert Gabbay, chief scientific and medical officer for the American Diabetes Association talked to Medtech Insight about diabetes tech, where it's headed, and what it could mean for preventative care.
You may also be interested in...
Elypta Drops Data Showing Power Of Metabolite-Based MCED Test
Elypta’s MIRAM kit for multi-cancer early detection performed well in a large-scale study.
Minute Insight: Intel-Penn Tie-Up Proves Federated Approach’s Power
Federated learning has taken another step forward thanks to new research that proves it is better at spotting brain tumors.
Snapshot: November Highlights
A selection of articles you might have missed from November 2022, during which In Vivo shone the spotlight on the Asia Pacific region.